Outcome of Chronic Daily Headache or Chronic Migraine

Chronic Daily Headache (SJ Wang, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Chronic Daily Headache

Abstract

Chronic daily headache (CDH) is a common neurological condition that affects 1–4 % of the general population. Recent epidemiological studies have shown that CDH is mainly represented by chronic migraine (CM). Owing to the frequent headaches, associated symptoms, and comorbid conditions associated with CDH/CM, disability, quality of life (QoL), economic burden, and treatment outcome have become important personal and social issues. There have been several studies assessing the disability, QoL, and economic burden associated with CDH/CM. These studies, conducted in different settings, consistently reported significantly higher disability and economic burden and lower QoL among CDH/CM patients compared to patients with episodic headache (EH) or episodic migraine (EM). Treatment outcome of CDH/CM is often poor. In this review, we describe and summarize the results of relevant studies performed to date.

Keywords

Chronic daily headache Chronic migraine Headache Burden Quality of life Cost Treatment 

Abbreviations

AMPP

American Migraine Prevalence and Prevention

BT-A

Botulinum toxin A

CDH

Chronic daily headache

CM

Chronic migraine

CTTH

Chronic tension-type headache

ED

Emergency department

EH

Episodic headache

EM

Episodic migraine

EUROHIS-QoL 8

European Health Interview Survey-QoL 8

HRQoL

Headache-related quality of life

IBMS

International Burden of Migraine Study

ICHD-2

The second edition of International Classification of Headache Disorders

ICHD-3 beta

The third beta edition of International Classification of Headache Disorders

MIDAS

Migraine disability assessment

MO

Medication overuse

MSQ

Migraine-Specific Quality of Life Questionnaire

QoL: Quality of Life RCM

Refractory chronic migraine

SF-36

36-item Short-Form Health Survey

TM

Transformed migraine

WHOQoL-BREF

Shortened version of World Health Organization Quality of Life Instrument-Abbreviation Version

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Dodick DW. Chronic daily headache. N Engl J Med. 2006;354(2):158–65.PubMedCrossRefGoogle Scholar
  2. 2.
    Schwedt TJ. Chronic migraine. Br Med J. 2014;348:g1416.CrossRefGoogle Scholar
  3. 3.
    Stark RJ, Ravishankar K, Siow HC, Lee KS, Pepperle R, Wang S-J. Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review. Cephalalgia. 2013;33(4):266–83.PubMedCrossRefGoogle Scholar
  4. 4.
    Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000;13(3):277–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Bigal M, Lipton R, Tepper S, Rapoport A, Sheftell F. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology. 2004;63(5):843–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Lu S, Fuh J, Chen W, Juang K, Wang S. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001;21(10):980–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRefGoogle Scholar
  8. 8.
    Headache Classificaation Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9–160.Google Scholar
  9. 9.
    Silberstein SD, Lipton RB, Dodick DW. Operational diagnostic criteria for chronic migraine: expert opinion. Headache. 2014;54(7):1258–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Manack AN, Buse DC, Lipton RB. Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep. 2011;15(1):70–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2009;30(5):599–609.Google Scholar
  12. 12.••
    Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–15. This international web-based cross-sectional study with participants from ten countries shed on the light of the severe disability of chronic migraine.PubMedCrossRefGoogle Scholar
  13. 13.
    Chong CD, Dodick DW, Schlaggar BL, Schwedt TJ. Atypical age-related cortical thinning in episodic migraine. Cephalalgia. 2014;34(14):1115–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Leonardi M, Raggi A. Burden of migraine: international perspectives. Neurol Sci. 2013;34 Suppl 1:S117–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14:1.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.••
    Lanteri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31(7):837–50. This article showed extensive reviews of quality of life, disability, and economic burden of chronic daily headache or chronic migraine with elegant figure and tables.PubMedCrossRefGoogle Scholar
  18. 18.
    Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43(4):336–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8 Suppl 1:S3–47.PubMedGoogle Scholar
  20. 20.
    Fiane I, Haugland ME, Stovner LJ, Zwart JA, Bovim G, Hagen K. Sick leave is related to frequencies of migraine and non-migrainous headache—the HUNT Study. Cephalalgia. 2006;26(8):960–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559–66.PubMedCrossRefGoogle Scholar
  22. 22.
    Lanteri-Minet M, Auray JP, El Hasnaoui A, Dartigues JF, Duru G, Henry P, et al. Prevalence and description of chronic daily headache in the general population in France. Pain. 2003;102(1–2):143–9.PubMedCrossRefGoogle Scholar
  23. 23.
    D’Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache. 2005;45(5):553–60.PubMedCrossRefGoogle Scholar
  24. 24.•
    Lanteri-Minet M. Economic burden and costs of chronic migraine. Curr Pain Headache Rep. 2014;18(1):1–6. An updated review on economic burden and costs of chronic migraine.CrossRefGoogle Scholar
  25. 25.
    Carod-Artal FJ. Tackling chronic migraine: current perspectives. J Pain Res. 2014;7:185–94.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci. 2004;25 Suppl 3:S105–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache. 2012;52(4):582–91.PubMedCrossRefGoogle Scholar
  28. 28.
    Queiroz LP, Silva Junior AA. The prevalence and impact of headache in Brazil. Headache. 2015;55 Suppl 1:32–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Zebenholzer K, Andree C, Lechner A, Broessner G, Lampl C, Luthringshausen G, et al. Prevalence, management and burden of episodic and chronic headaches—a cross-sectional multicentre study in eight Austrian headache centres. J Headache Pain. 2015;16(1):531.PubMedCrossRefGoogle Scholar
  30. 30.
    D’Amico D, Usai S, Grazzi L, Rigamonti A, Solari A, Leone M, et al. Quality of life and disability in primary chronic daily headaches. Neurol Sci. 2003;24 Suppl 2:S97–100.PubMedGoogle Scholar
  31. 31.
    Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.PubMedCrossRefGoogle Scholar
  32. 32.•
    Abu Bakar N, Tanprawate S, Lambru G, Torkamani M, Jahanshahi M, Matharu M. Quality of life in primary headache disorders: a review. Cephalalgia. 2015:0333102415580099. Recent update of quality of life of migraine, tension-type headache, and chronic daily headache focusing with detailed description of assessing instrument and study quality . Google Scholar
  33. 33.
    Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35(7):563–78.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, et al. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache. 2012;52(3):409–21.PubMedCrossRefGoogle Scholar
  35. 35.
    da Rocha NS, Power MJ, Bushnell DM, Fleck MP. The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF. Value Health. 2012;15(3):449–57.PubMedCrossRefGoogle Scholar
  36. 36.
    Ware Jr JE, Sherbourne CD, The MOS. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.PubMedCrossRefGoogle Scholar
  37. 37.
    Duru G, Auray JP, Gaudin AF, Dartigues JF, Henry P, Lanteri-Minet M, et al. Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache. 2004;44(6):571–80.PubMedCrossRefGoogle Scholar
  38. 38.
    Barton-Donovan K, Blanchard EB. Psychosocial aspects of chronic daily headache. J Headache Pain. 2005;6(1):30–9.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Guitera V, Munoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: a study in a general population. Neurology. 2002;58(7):1062–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41(6):573–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain. 2001;89(2–3):285–92.PubMedCrossRefGoogle Scholar
  42. 42.
    Coeytaux RR, Spierings EL. Prognostic factors, disability, and functional status among patients in a headache specialty practice. Cephalalgia. 2006;26(1):7–13. doi:10.1111/j.1468-2982.2005.00976.x.PubMedCrossRefGoogle Scholar
  43. 43.
    Manzoni GC, Torelli P. Epidemiological classification and social impact of chronic headache. Intern Emerg Med. 2010;5 Suppl 1:S1–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Cavallini A, Micieli G, Bussone G, Rossi F, Nappi G. Headache and quality of life. Headache. 1995;35(1):29–35.PubMedCrossRefGoogle Scholar
  45. 45.
    Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ. The global campaign, world health organization and lifting the burden: collaboration in action. J Headache Pain. 2011;12(3):273–4.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Steiner TJ, Gururaj G, Andree C, Katsarava Z, Ayzenberg I, Yu SY, et al. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain. 2014;15:3.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32.PubMedCrossRefGoogle Scholar
  48. 48.
    Lipton R, Scher A, Steiner T, Bigal M, Kolodner K, Liberman J, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003;60(3):441–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Sanderson JC, Devine EB, Lipton RB, Bloudek LM, Varon SF, Blumenfeld AM, et al. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013;84(12):1309–17.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009;49(4):498–508.PubMedCrossRefGoogle Scholar
  51. 51.
    Wang SJ, Wang PJ, Fuh JL, Peng KP, Ng K. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan. Cephalalgia. 2013;33(3):171–81.PubMedCrossRefGoogle Scholar
  52. 52.
    Park JW, Moon HS, Kim JM, Lee KS, Chu MK. Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol. 2014;10(3):236–43.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52(1):8–14.PubMedCrossRefGoogle Scholar
  54. 54.
    Lionetto L, Negro A, Palmisani S, Gentile G, Fiore MRD, Mercieri M, et al. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs. 2012;17(3):393–406.PubMedCrossRefGoogle Scholar
  55. 55.•
    Mulleners WM, McCrory DC, Linde M. Antiepileptics in migraine prophylaxis: an updated Cochrane review. Cephalalgia. 2015;35(1):51–62. A concise and updated review of migraine and chronic migraine prophylaxis.PubMedCrossRefGoogle Scholar
  56. 56.
    Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the preventive treatment of refractory migraine. Headache. 2008;48(9):1337–42.PubMedCrossRefGoogle Scholar
  57. 57.
    Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Vilchez JS, Rodriguez-Lopez CM. Pregabalin in the treatment of chronic migraine: an open-label study. Clin Neuropharmacol. 2010;33(1):35–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Edvardsson B. Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study. Springer Plus. 2013;2(1):479.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Magalhães E, Menezes C, Cardeal M, Melo A. Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. Clin Neurol Neurosurg. 2010;112(6):463–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Pascual-Gómez J, Alañá-García M, Oterino A, Leira R, Láinez-Andrés J. Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate. Rev Neurol. 2007;47(9):449–51.Google Scholar
  61. 61.
    Saper JR, Lake AE, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double‐blind, placebo‐controlled, multicenter outcome study. Headache. 2002;42(6):470–82.PubMedCrossRefGoogle Scholar
  62. 62.
    Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain. 2008;9(1):37–41.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Pistoia F, Sacco S, Carolei A. Behavioral therapy for chronic migraine. Curr Pain Headache Rep. 2013;17(1):1–8.CrossRefGoogle Scholar
  64. 64.
    Reed K, Black S, Banta C, Will K. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2009;30(3):260–71.Google Scholar
  65. 65.
    Yang C, Chang M, Liu P, Li T, Hsieh C, Hwang K, et al. Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial. Cephalalgia. 2011;31(15):1510–21.PubMedCrossRefGoogle Scholar
  66. 66.
    Diener H, Bussone G, Van Oene J, Lahaye M, Schwalen S, Goadsby P. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814–23.PubMedCrossRefGoogle Scholar
  67. 67.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double‐blind, placebo‐controlled trial. Headache. 2007;47(2):170–80.PubMedCrossRefGoogle Scholar
  68. 68.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.PubMedCrossRefGoogle Scholar
  69. 69.
    Storey J, Calder C, Hart D, Potter D. Topiramate in migraine prevention: a double‐blind, placebo‐controlled study. Headache. 2001;41(10):968–75.PubMedCrossRefGoogle Scholar
  70. 70.
    Aurora S, Dodick D, Turkel C, DeGryse R, Silberstein S, Lipton R, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30(7):793–803.PubMedCrossRefGoogle Scholar
  71. 71.
    Diener H, Dodick D, Aurora S, Turkel C, DeGryse R, Lipton R, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804–14.PubMedCrossRefGoogle Scholar
  72. 72.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double‐blind, randomized, placebo‐controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–36.PubMedCrossRefGoogle Scholar
  73. 73.
    Naumann M, So Y, Argoff C, Childers M, Dykstra D, Gronseth G, et al. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1707–14.PubMedCrossRefGoogle Scholar
  74. 74.
    Spira PJ, Beran RG. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology. 2003;61(12):1753–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Schulman EA, Lee Peterlin B, Lake AE, Lipton RB, Hanlon A, Siegel S, et al. Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache. 2009;49(4):509–18.PubMedCrossRefGoogle Scholar
  76. 76.
    Irimia P, Palma J-A, Fernandez-Torron R, Martinez-Vila E. Refractory migraine in a headache clinic population. BMC Neurol. 2011;11(1):94.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Dodick DW, Silberstein SD, Reed KL, Deer TR, Slavin KV, Huh B, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2014;35(4):344–58.PubMedCrossRefGoogle Scholar
  78. 78.
    DaSilva AF, Mendonca ME, Zaghi S, Lopes M, DosSantos MF, Spierings EL, et al. tDCS‐Induced analgesia and electrical fields in pain‐related neural networks in chronic migraine. Headache. 2012;52(8):1283–95.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Neurology, Dongtan Sacred Heart HospitalHallym University College of MedicineHwaseong-siSouth Korea
  2. 2.Department of NeurologyEwha Womans University School of MedicineYangcheon-guSouth Korea
  3. 3.Department of Neurology, Sacred Heart HospitalHallym University College of MedicineAnyang-siSouth Korea

Personalised recommendations